Biosimilar knowledge and viewpoints among Brazilian inflammatory bowel disease patients.

Date publication

janvier 2021

Journal

Therapeutic advances in gastroenterology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Garcia KS, Facas BP, Machado MB, Teixeira FV, Avedano L, Lönnfors S, Hossne RS, Peyrin-Biroulet L, Queiroz NSF

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34046083

Résumé

In this analysis we aimed to describe Brazilian inflammatory bowel disease (IBD) patients' knowledge and perceptions regarding biosimilars and compare with viewpoints from non-Brazilian patients.

Mots clés

adalimumab, biosimilar, inflammatory bowel disease, infliximab

Référence

Therap Adv Gastroenterol. 2021 ;14:17562848211013249